Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Tamar Thompson currently holds 3,773 shares of Avidity Biosciences, Inc. (RNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tamar Thompson has been a net neutral trader of RNA stock. They have purchased $0 and sold $0 worth of shares.
Tamar Thompson's most recent insider trade was on Dec 8, 2025, when they sold 1,413 shares at $0.00 per share.
Tamar Thompson serves as Executive at Avidity Biosciences, Inc. (RNA). They have executed 7 insider transactions totaling $0 over their tenure at the company.
Tamar Thompson holds the position of Executive at Avidity Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Tamar Thompson has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Tamar Thompson was on Dec 8, 2025, when they sold $0 worth of CPRX shares. This transaction involved 1,413 shares at N/A per share.
Tamar Thompson currently owns 3,773 shares of Avidity Biosciences, Inc. (RNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Tamar Thompson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Tamar Thompson has 7 Form 4 filings on record as an insider at Avidity Biosciences, Inc..
Set alerts for Tamar Thompson and 40,000+ other insiders.